Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
NOTO
|
ENSG00000214513.3 | notochord homeobox |
VSX2
|
ENSG00000119614.2 | visual system homeobox 2 |
DLX2
|
ENSG00000115844.6 | distal-less homeobox 2 |
DLX6
|
ENSG00000006377.9 | distal-less homeobox 6 |
NKX6-1
|
ENSG00000163623.5 | NK6 homeobox 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
NKX6-1 | hg19_v2_chr4_-_85418103_85418103 | 0.28 | 1.3e-01 | Click! |
VSX2 | hg19_v2_chr14_+_74706150_74706175 | 0.16 | 3.7e-01 | Click! |
DLX6 | hg19_v2_chr7_+_96635277_96635301 | 0.14 | 4.5e-01 | Click! |
NOTO | hg19_v2_chr2_+_73429386_73429386 | -0.08 | 6.5e-01 | Click! |
DLX2 | hg19_v2_chr2_-_172967621_172967637 | 0.04 | 8.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_10421853 | 8.71 |
ENST00000226207.5
|
MYH1
|
myosin, heavy chain 1, skeletal muscle, adult |
chr6_-_87804815 | 7.67 |
ENST00000369582.2
|
CGA
|
glycoprotein hormones, alpha polypeptide |
chr4_-_138453606 | 7.52 |
ENST00000412923.2
ENST00000344876.4 ENST00000507846.1 ENST00000510305.1 |
PCDH18
|
protocadherin 18 |
chr8_+_92261516 | 6.98 |
ENST00000276609.3
ENST00000309536.2 |
SLC26A7
|
solute carrier family 26 (anion exchanger), member 7 |
chr4_-_138453559 | 5.51 |
ENST00000511115.1
|
PCDH18
|
protocadherin 18 |
chr1_+_160160346 | 5.41 |
ENST00000368078.3
|
CASQ1
|
calsequestrin 1 (fast-twitch, skeletal muscle) |
chr1_+_160160283 | 5.24 |
ENST00000368079.3
|
CASQ1
|
calsequestrin 1 (fast-twitch, skeletal muscle) |
chr21_+_17442799 | 4.62 |
ENST00000602580.1
ENST00000458468.1 ENST00000602935.1 |
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr6_+_78400375 | 4.28 |
ENST00000602452.2
|
MEI4
|
meiosis-specific 4 homolog (S. cerevisiae) |
chr5_+_174151536 | 4.22 |
ENST00000239243.6
ENST00000507785.1 |
MSX2
|
msh homeobox 2 |
chr7_-_107642348 | 3.99 |
ENST00000393561.1
|
LAMB1
|
laminin, beta 1 |
chr12_-_16761007 | 3.97 |
ENST00000354662.1
ENST00000441439.2 |
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr10_+_24755416 | 3.97 |
ENST00000396446.1
ENST00000396445.1 ENST00000376451.2 |
KIAA1217
|
KIAA1217 |
chr14_-_36988882 | 3.91 |
ENST00000498187.2
|
NKX2-1
|
NK2 homeobox 1 |
chr7_-_27169801 | 3.80 |
ENST00000511914.1
|
HOXA4
|
homeobox A4 |
chr6_-_123958141 | 3.67 |
ENST00000334268.4
|
TRDN
|
triadin |
chr10_+_123951957 | 3.62 |
ENST00000514539.1
|
TACC2
|
transforming, acidic coiled-coil containing protein 2 |
chr12_+_81110684 | 3.58 |
ENST00000228644.3
|
MYF5
|
myogenic factor 5 |
chr7_+_73442487 | 3.46 |
ENST00000380575.4
ENST00000380584.4 ENST00000458204.1 ENST00000357036.5 ENST00000417091.1 ENST00000429192.1 ENST00000442310.1 ENST00000380553.4 ENST00000380576.5 ENST00000428787.1 ENST00000320399.6 |
ELN
|
elastin |
chr6_-_123957942 | 3.27 |
ENST00000398178.3
|
TRDN
|
triadin |
chr6_-_100912785 | 3.24 |
ENST00000369208.3
|
SIM1
|
single-minded family bHLH transcription factor 1 |
chr3_+_2933893 | 3.20 |
ENST00000397459.2
|
CNTN4
|
contactin 4 |
chr13_-_36050819 | 3.15 |
ENST00000379919.4
|
MAB21L1
|
mab-21-like 1 (C. elegans) |
chr4_-_111563076 | 3.15 |
ENST00000354925.2
ENST00000511990.1 |
PITX2
|
paired-like homeodomain 2 |
chr17_+_59489112 | 3.08 |
ENST00000335108.2
|
C17orf82
|
chromosome 17 open reading frame 82 |
chr17_-_77924627 | 3.04 |
ENST00000572862.1
ENST00000573782.1 ENST00000574427.1 ENST00000570373.1 ENST00000340848.7 ENST00000576768.1 |
TBC1D16
|
TBC1 domain family, member 16 |
chr20_-_50419055 | 2.98 |
ENST00000217086.4
|
SALL4
|
spalt-like transcription factor 4 |
chr8_+_121137333 | 2.90 |
ENST00000309791.4
ENST00000297848.3 ENST00000247781.3 |
COL14A1
|
collagen, type XIV, alpha 1 |
chr12_+_41831485 | 2.77 |
ENST00000539469.2
ENST00000298919.7 |
PDZRN4
|
PDZ domain containing ring finger 4 |
chr13_-_38172863 | 2.72 |
ENST00000541481.1
ENST00000379743.4 ENST00000379742.4 ENST00000379749.4 ENST00000541179.1 ENST00000379747.4 |
POSTN
|
periostin, osteoblast specific factor |
chr20_-_50418947 | 2.72 |
ENST00000371539.3
|
SALL4
|
spalt-like transcription factor 4 |
chr7_+_73442422 | 2.67 |
ENST00000358929.4
ENST00000431562.1 ENST00000320492.7 ENST00000438906.1 |
ELN
|
elastin |
chr12_-_16761117 | 2.65 |
ENST00000538051.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr4_-_111563279 | 2.64 |
ENST00000511837.1
|
PITX2
|
paired-like homeodomain 2 |
chr12_+_54378923 | 2.61 |
ENST00000303460.4
|
HOXC10
|
homeobox C10 |
chr20_-_50418972 | 2.60 |
ENST00000395997.3
|
SALL4
|
spalt-like transcription factor 4 |
chr7_+_73442457 | 2.56 |
ENST00000438880.1
ENST00000414324.1 ENST00000380562.4 |
ELN
|
elastin |
chr6_-_123958051 | 2.45 |
ENST00000546248.1
|
TRDN
|
triadin |
chr8_-_109799793 | 2.41 |
ENST00000297459.3
|
TMEM74
|
transmembrane protein 74 |
chr11_-_13517565 | 2.38 |
ENST00000282091.1
ENST00000529816.1 |
PTH
|
parathyroid hormone |
chr7_-_73038822 | 2.36 |
ENST00000414749.2
ENST00000429400.2 ENST00000434326.1 |
MLXIPL
|
MLX interacting protein-like |
chr14_-_38064198 | 2.30 |
ENST00000250448.2
|
FOXA1
|
forkhead box A1 |
chr2_+_234826016 | 2.30 |
ENST00000324695.4
ENST00000433712.2 |
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8 |
chr9_-_98189055 | 2.30 |
ENST00000433644.2
|
RP11-435O5.2
|
RP11-435O5.2 |
chr7_-_73038867 | 2.28 |
ENST00000313375.3
ENST00000354613.1 ENST00000395189.1 ENST00000453275.1 |
MLXIPL
|
MLX interacting protein-like |
chr2_+_78143006 | 2.26 |
ENST00000443419.1
|
AC073628.1
|
AC073628.1 |
chr14_-_92413353 | 2.22 |
ENST00000556154.1
|
FBLN5
|
fibulin 5 |
chr2_-_183291741 | 2.22 |
ENST00000351439.5
ENST00000409365.1 |
PDE1A
|
phosphodiesterase 1A, calmodulin-dependent |
chr7_+_73442102 | 2.17 |
ENST00000445912.1
ENST00000252034.7 |
ELN
|
elastin |
chr8_-_42234745 | 2.11 |
ENST00000220812.2
|
DKK4
|
dickkopf WNT signaling pathway inhibitor 4 |
chr18_+_76740189 | 2.10 |
ENST00000537592.2
ENST00000575389.2 |
SALL3
|
spalt-like transcription factor 3 |
chr11_+_65554493 | 2.10 |
ENST00000335987.3
|
OVOL1
|
ovo-like zinc finger 1 |
chr4_-_186696425 | 2.09 |
ENST00000430503.1
ENST00000319454.6 ENST00000450341.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
chr6_+_4087664 | 2.06 |
ENST00000430835.2
|
C6orf201
|
chromosome 6 open reading frame 201 |
chr1_-_95783809 | 2.06 |
ENST00000423410.1
|
RP4-586O15.1
|
RP4-586O15.1 |
chr1_-_234667504 | 2.03 |
ENST00000421207.1
ENST00000435574.1 |
RP5-855F14.1
|
RP5-855F14.1 |
chr6_-_123958111 | 2.02 |
ENST00000542443.1
|
TRDN
|
triadin |
chr17_-_10452929 | 2.01 |
ENST00000532183.2
ENST00000397183.2 ENST00000420805.1 |
MYH2
|
myosin, heavy chain 2, skeletal muscle, adult |
chr12_+_81101277 | 2.00 |
ENST00000228641.3
|
MYF6
|
myogenic factor 6 (herculin) |
chr2_+_3800169 | 1.99 |
ENST00000399143.3
|
DCDC2C
|
doublecortin domain containing 2C |
chr7_-_14029283 | 1.99 |
ENST00000433547.1
ENST00000405192.2 |
ETV1
|
ets variant 1 |
chr22_-_28490123 | 1.95 |
ENST00000442232.1
|
TTC28
|
tetratricopeptide repeat domain 28 |
chr10_-_48416849 | 1.92 |
ENST00000249598.1
|
GDF2
|
growth differentiation factor 2 |
chr21_+_17443521 | 1.91 |
ENST00000456342.1
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr8_+_24298531 | 1.90 |
ENST00000175238.6
|
ADAM7
|
ADAM metallopeptidase domain 7 |
chr8_+_24298597 | 1.90 |
ENST00000380789.1
|
ADAM7
|
ADAM metallopeptidase domain 7 |
chr4_+_169418195 | 1.87 |
ENST00000261509.6
ENST00000335742.7 |
PALLD
|
palladin, cytoskeletal associated protein |
chr19_-_7698599 | 1.82 |
ENST00000311069.5
|
PCP2
|
Purkinje cell protein 2 |
chr13_-_86373536 | 1.80 |
ENST00000400286.2
|
SLITRK6
|
SLIT and NTRK-like family, member 6 |
chr3_-_151034734 | 1.79 |
ENST00000260843.4
|
GPR87
|
G protein-coupled receptor 87 |
chr20_+_56136136 | 1.77 |
ENST00000319441.4
ENST00000543666.1 |
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble) |
chr21_-_40033618 | 1.77 |
ENST00000417133.2
ENST00000398910.1 ENST00000442448.1 |
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog |
chr10_+_118083919 | 1.76 |
ENST00000333254.3
|
CCDC172
|
coiled-coil domain containing 172 |
chrX_+_99839799 | 1.74 |
ENST00000373031.4
|
TNMD
|
tenomodulin |
chr14_-_92413727 | 1.74 |
ENST00000267620.10
|
FBLN5
|
fibulin 5 |
chr15_-_37393406 | 1.73 |
ENST00000338564.5
ENST00000558313.1 ENST00000340545.5 |
MEIS2
|
Meis homeobox 2 |
chr9_-_95166841 | 1.73 |
ENST00000262551.4
|
OGN
|
osteoglycin |
chr9_-_95166976 | 1.72 |
ENST00000447356.1
|
OGN
|
osteoglycin |
chr14_-_37051798 | 1.72 |
ENST00000258829.5
|
NKX2-8
|
NK2 homeobox 8 |
chr17_-_64225508 | 1.70 |
ENST00000205948.6
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I) |
chr17_-_9694614 | 1.69 |
ENST00000330255.5
ENST00000571134.1 |
DHRS7C
|
dehydrogenase/reductase (SDR family) member 7C |
chr6_-_76203454 | 1.69 |
ENST00000237172.7
|
FILIP1
|
filamin A interacting protein 1 |
chr3_-_157824292 | 1.67 |
ENST00000483851.2
|
SHOX2
|
short stature homeobox 2 |
chr5_-_1882858 | 1.65 |
ENST00000511126.1
ENST00000231357.2 |
IRX4
|
iroquois homeobox 4 |
chr3_+_148447887 | 1.64 |
ENST00000475347.1
ENST00000474935.1 ENST00000461609.1 |
AGTR1
|
angiotensin II receptor, type 1 |
chr5_-_56778635 | 1.63 |
ENST00000423391.1
|
ACTBL2
|
actin, beta-like 2 |
chr7_-_27179814 | 1.60 |
ENST00000522788.1
ENST00000521779.1 |
HOXA3
|
homeobox A3 |
chr21_+_17443434 | 1.59 |
ENST00000400178.2
|
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr4_+_77356248 | 1.58 |
ENST00000296043.6
|
SHROOM3
|
shroom family member 3 |
chr5_+_53751445 | 1.57 |
ENST00000302005.1
|
HSPB3
|
heat shock 27kDa protein 3 |
chr14_-_61116168 | 1.57 |
ENST00000247182.6
|
SIX1
|
SIX homeobox 1 |
chr9_-_95166884 | 1.56 |
ENST00000375561.5
|
OGN
|
osteoglycin |
chr4_+_105828537 | 1.55 |
ENST00000515649.1
|
RP11-556I14.1
|
RP11-556I14.1 |
chr14_-_54423529 | 1.55 |
ENST00000245451.4
ENST00000559087.1 |
BMP4
|
bone morphogenetic protein 4 |
chr7_-_107443652 | 1.52 |
ENST00000340010.5
ENST00000422236.2 ENST00000453332.1 |
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3 |
chr8_-_42358742 | 1.52 |
ENST00000517366.1
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
chr1_+_214161272 | 1.47 |
ENST00000498508.2
ENST00000366958.4 |
PROX1
|
prospero homeobox 1 |
chr2_-_180610767 | 1.40 |
ENST00000409343.1
|
ZNF385B
|
zinc finger protein 385B |
chr15_-_54025300 | 1.38 |
ENST00000559418.1
|
WDR72
|
WD repeat domain 72 |
chr7_-_14029515 | 1.35 |
ENST00000430479.1
ENST00000405218.2 ENST00000343495.5 |
ETV1
|
ets variant 1 |
chr11_-_26593649 | 1.34 |
ENST00000455601.2
|
MUC15
|
mucin 15, cell surface associated |
chr6_-_76203345 | 1.32 |
ENST00000393004.2
|
FILIP1
|
filamin A interacting protein 1 |
chr17_-_46671323 | 1.32 |
ENST00000239151.5
|
HOXB5
|
homeobox B5 |
chr17_-_38938786 | 1.31 |
ENST00000301656.3
|
KRT27
|
keratin 27 |
chr12_-_16430619 | 1.30 |
ENST00000344941.3
|
SLC15A5
|
solute carrier family 15, member 5 |
chr8_+_77593474 | 1.29 |
ENST00000455469.2
ENST00000050961.6 |
ZFHX4
|
zinc finger homeobox 4 |
chr12_-_16759440 | 1.29 |
ENST00000537304.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr4_-_186696515 | 1.29 |
ENST00000456596.1
ENST00000414724.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
chr2_-_152589670 | 1.27 |
ENST00000604864.1
ENST00000603639.1 |
NEB
|
nebulin |
chr21_-_31864275 | 1.26 |
ENST00000334063.4
|
KRTAP19-3
|
keratin associated protein 19-3 |
chr11_-_26593779 | 1.26 |
ENST00000529533.1
|
MUC15
|
mucin 15, cell surface associated |
chr12_-_6233828 | 1.25 |
ENST00000572068.1
ENST00000261405.5 |
VWF
|
von Willebrand factor |
chr4_-_186696561 | 1.22 |
ENST00000445115.1
ENST00000451701.1 ENST00000457247.1 ENST00000435480.1 ENST00000425679.1 ENST00000457934.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
chr1_+_61547894 | 1.21 |
ENST00000403491.3
|
NFIA
|
nuclear factor I/A |
chr1_+_160370344 | 1.21 |
ENST00000368061.2
|
VANGL2
|
VANGL planar cell polarity protein 2 |
chrX_+_105937068 | 1.21 |
ENST00000324342.3
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
chrX_-_10851762 | 1.20 |
ENST00000380785.1
ENST00000380787.1 |
MID1
|
midline 1 (Opitz/BBB syndrome) |
chr8_+_24298438 | 1.19 |
ENST00000441335.2
|
ADAM7
|
ADAM metallopeptidase domain 7 |
chr4_+_41614909 | 1.18 |
ENST00000509454.1
ENST00000396595.3 ENST00000381753.4 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr11_-_16419067 | 1.16 |
ENST00000533411.1
|
SOX6
|
SRY (sex determining region Y)-box 6 |
chr11_-_26593677 | 1.15 |
ENST00000527569.1
|
MUC15
|
mucin 15, cell surface associated |
chr2_+_176987088 | 1.15 |
ENST00000249499.6
|
HOXD9
|
homeobox D9 |
chr4_+_71494461 | 1.15 |
ENST00000396073.3
|
ENAM
|
enamelin |
chrX_+_43515467 | 1.14 |
ENST00000338702.3
ENST00000542639.1 |
MAOA
|
monoamine oxidase A |
chr4_+_169013666 | 1.14 |
ENST00000359299.3
|
ANXA10
|
annexin A10 |
chrX_-_106243451 | 1.13 |
ENST00000355610.4
ENST00000535534.1 |
MORC4
|
MORC family CW-type zinc finger 4 |
chr5_+_31193847 | 1.13 |
ENST00000514738.1
ENST00000265071.2 |
CDH6
|
cadherin 6, type 2, K-cadherin (fetal kidney) |
chr12_-_16759711 | 1.13 |
ENST00000447609.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr4_-_74486217 | 1.12 |
ENST00000335049.5
ENST00000307439.5 |
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr4_+_71108300 | 1.12 |
ENST00000304954.3
|
CSN3
|
casein kappa |
chr11_-_2160180 | 1.11 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr6_-_31107127 | 1.10 |
ENST00000259845.4
|
PSORS1C2
|
psoriasis susceptibility 1 candidate 2 |
chr3_+_159557637 | 1.10 |
ENST00000445224.2
|
SCHIP1
|
schwannomin interacting protein 1 |
chr12_+_108168162 | 1.09 |
ENST00000342331.4
|
ASCL4
|
achaete-scute family bHLH transcription factor 4 |
chr12_-_102874330 | 1.08 |
ENST00000307046.8
|
IGF1
|
insulin-like growth factor 1 (somatomedin C) |
chr5_+_176811431 | 1.08 |
ENST00000512593.1
ENST00000324417.5 |
SLC34A1
|
solute carrier family 34 (type II sodium/phosphate contransporter), member 1 |
chr6_+_105404899 | 1.08 |
ENST00000345080.4
|
LIN28B
|
lin-28 homolog B (C. elegans) |
chr17_+_68071389 | 1.07 |
ENST00000283936.1
ENST00000392671.1 |
KCNJ16
|
potassium inwardly-rectifying channel, subfamily J, member 16 |
chr1_-_178840157 | 1.05 |
ENST00000367629.1
ENST00000234816.2 |
ANGPTL1
|
angiopoietin-like 1 |
chr19_-_7697857 | 1.04 |
ENST00000598935.1
|
PCP2
|
Purkinje cell protein 2 |
chr2_+_171571827 | 1.04 |
ENST00000375281.3
|
SP5
|
Sp5 transcription factor |
chr4_+_183065793 | 1.03 |
ENST00000512480.1
|
TENM3
|
teneurin transmembrane protein 3 |
chr1_-_94586651 | 1.01 |
ENST00000535735.1
ENST00000370225.3 |
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4 |
chr2_-_171571077 | 1.01 |
ENST00000409786.1
|
AC007405.2
|
long intergenic non-protein coding RNA 1124 |
chr9_+_130026756 | 1.01 |
ENST00000314904.5
ENST00000373387.4 |
GARNL3
|
GTPase activating Rap/RanGAP domain-like 3 |
chr6_+_118869452 | 1.01 |
ENST00000357525.5
|
PLN
|
phospholamban |
chr3_-_120400960 | 1.01 |
ENST00000476082.2
|
HGD
|
homogentisate 1,2-dioxygenase |
chrX_+_105936982 | 1.00 |
ENST00000418562.1
|
RNF128
|
ring finger protein 128, E3 ubiquitin protein ligase |
chr12_-_86650045 | 1.00 |
ENST00000604798.1
|
MGAT4C
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
chr6_-_76072719 | 1.00 |
ENST00000370020.1
|
FILIP1
|
filamin A interacting protein 1 |
chr12_-_28123206 | 1.00 |
ENST00000542963.1
ENST00000535992.1 |
PTHLH
|
parathyroid hormone-like hormone |
chr13_-_36788718 | 0.99 |
ENST00000317764.6
ENST00000379881.3 |
SOHLH2
|
spermatogenesis and oogenesis specific basic helix-loop-helix 2 |
chr3_+_2553281 | 0.99 |
ENST00000434053.1
|
CNTN4
|
contactin 4 |
chr12_+_26348582 | 0.98 |
ENST00000535504.1
|
SSPN
|
sarcospan |
chr10_-_33623310 | 0.98 |
ENST00000395995.1
ENST00000374823.5 ENST00000374821.5 ENST00000374816.3 |
NRP1
|
neuropilin 1 |
chr8_+_77593448 | 0.98 |
ENST00000521891.2
|
ZFHX4
|
zinc finger homeobox 4 |
chr1_-_159832438 | 0.98 |
ENST00000368100.1
|
VSIG8
|
V-set and immunoglobulin domain containing 8 |
chr1_+_68150744 | 0.97 |
ENST00000370986.4
ENST00000370985.3 |
GADD45A
|
growth arrest and DNA-damage-inducible, alpha |
chr12_+_52695617 | 0.96 |
ENST00000293525.5
|
KRT86
|
keratin 86 |
chr14_+_38065052 | 0.95 |
ENST00000556845.1
|
TTC6
|
tetratricopeptide repeat domain 6 |
chr2_+_171034646 | 0.95 |
ENST00000409044.3
ENST00000408978.4 |
MYO3B
|
myosin IIIB |
chr4_-_74486109 | 0.94 |
ENST00000395777.2
|
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr12_+_54378849 | 0.94 |
ENST00000515593.1
|
HOXC10
|
homeobox C10 |
chr4_+_151503077 | 0.93 |
ENST00000317605.4
|
MAB21L2
|
mab-21-like 2 (C. elegans) |
chr10_-_102989551 | 0.93 |
ENST00000370193.2
|
LBX1
|
ladybird homeobox 1 |
chr17_+_48243352 | 0.93 |
ENST00000344627.6
ENST00000262018.3 ENST00000543315.1 ENST00000451235.2 ENST00000511303.1 |
SGCA
|
sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) |
chr6_+_151646800 | 0.93 |
ENST00000354675.6
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr12_-_28122980 | 0.93 |
ENST00000395868.3
ENST00000534890.1 |
PTHLH
|
parathyroid hormone-like hormone |
chr12_+_18414446 | 0.92 |
ENST00000433979.1
|
PIK3C2G
|
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma |
chr11_-_8290263 | 0.92 |
ENST00000428101.2
|
LMO1
|
LIM domain only 1 (rhombotin 1) |
chr3_-_57233966 | 0.91 |
ENST00000473921.1
ENST00000295934.3 |
HESX1
|
HESX homeobox 1 |
chr1_-_185597619 | 0.91 |
ENST00000608417.1
ENST00000436955.1 |
GS1-204I12.1
|
GS1-204I12.1 |
chr1_-_57045228 | 0.91 |
ENST00000371250.3
|
PPAP2B
|
phosphatidic acid phosphatase type 2B |
chr4_+_88571429 | 0.91 |
ENST00000339673.6
ENST00000282479.7 |
DMP1
|
dentin matrix acidic phosphoprotein 1 |
chr20_+_42187682 | 0.91 |
ENST00000373092.3
ENST00000373077.1 |
SGK2
|
serum/glucocorticoid regulated kinase 2 |
chr13_+_110958124 | 0.91 |
ENST00000400163.2
|
COL4A2
|
collagen, type IV, alpha 2 |
chr10_+_119302508 | 0.91 |
ENST00000442245.4
|
EMX2
|
empty spiracles homeobox 2 |
chr14_-_54425475 | 0.91 |
ENST00000559642.1
|
BMP4
|
bone morphogenetic protein 4 |
chr12_-_16760021 | 0.91 |
ENST00000540445.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr8_-_49834299 | 0.90 |
ENST00000396822.1
|
SNAI2
|
snail family zinc finger 2 |
chr9_-_16253112 | 0.90 |
ENST00000380683.1
|
C9orf92
|
chromosome 9 open reading frame 92 |
chr14_-_95236551 | 0.89 |
ENST00000238558.3
|
GSC
|
goosecoid homeobox |
chr8_-_101661887 | 0.89 |
ENST00000311812.2
|
SNX31
|
sorting nexin 31 |
chrX_-_139047669 | 0.88 |
ENST00000370540.1
|
CXorf66
|
chromosome X open reading frame 66 |
chr12_-_71031185 | 0.87 |
ENST00000548122.1
ENST00000551525.1 ENST00000550358.1 |
PTPRB
|
protein tyrosine phosphatase, receptor type, B |
chr4_+_119809984 | 0.87 |
ENST00000307142.4
ENST00000448416.2 ENST00000429713.2 |
SYNPO2
|
synaptopodin 2 |
chr15_-_90222610 | 0.87 |
ENST00000300055.5
|
PLIN1
|
perilipin 1 |
chrX_-_110507098 | 0.87 |
ENST00000541758.1
|
CAPN6
|
calpain 6 |
chr15_-_90222642 | 0.86 |
ENST00000430628.2
|
PLIN1
|
perilipin 1 |
chr17_-_46690839 | 0.86 |
ENST00000498634.2
|
HOXB8
|
homeobox B8 |
chr15_-_98836406 | 0.86 |
ENST00000560360.1
|
CTD-2544M6.1
|
CTD-2544M6.1 |
chr12_-_86650077 | 0.85 |
ENST00000552808.2
ENST00000547225.1 |
MGAT4C
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
chr7_+_116660246 | 0.85 |
ENST00000434836.1
ENST00000393443.1 ENST00000465133.1 ENST00000477742.1 ENST00000393447.4 ENST00000393444.3 |
ST7
|
suppression of tumorigenicity 7 |
chr8_+_22424551 | 0.85 |
ENST00000523348.1
|
SORBS3
|
sorbin and SH3 domain containing 3 |
chr4_+_119810134 | 0.85 |
ENST00000434046.2
|
SYNPO2
|
synaptopodin 2 |
chr22_-_32860427 | 0.84 |
ENST00000534972.1
ENST00000397450.1 ENST00000397452.1 |
BPIFC
|
BPI fold containing family C |
chr17_-_10372875 | 0.83 |
ENST00000255381.2
|
MYH4
|
myosin, heavy chain 4, skeletal muscle |
chr4_-_74486347 | 0.82 |
ENST00000342081.3
|
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr17_-_7167279 | 0.81 |
ENST00000571932.2
|
CLDN7
|
claudin 7 |
chr5_-_126409159 | 0.81 |
ENST00000607731.1
ENST00000535381.1 ENST00000296662.5 ENST00000509733.3 |
C5orf63
|
chromosome 5 open reading frame 63 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 11.4 | GO:1901846 | positive regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901846) |
1.4 | 4.2 | GO:0051795 | positive regulation of catagen(GO:0051795) activation of meiosis(GO:0090427) |
1.2 | 5.8 | GO:0060127 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) superior vena cava morphogenesis(GO:0060578) |
0.8 | 10.6 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.8 | 11.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.8 | 4.0 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.8 | 2.4 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.8 | 1.6 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.8 | 2.3 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
0.7 | 2.2 | GO:0002194 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.7 | 4.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.6 | 3.0 | GO:1904075 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.6 | 4.2 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.6 | 1.7 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.5 | 1.6 | GO:0010159 | specification of organ position(GO:0010159) |
0.5 | 2.1 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.5 | 7.3 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.5 | 2.5 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.5 | 8.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.5 | 9.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.5 | 2.7 | GO:0032571 | response to vitamin K(GO:0032571) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) bone regeneration(GO:1990523) |
0.4 | 1.8 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.4 | 1.6 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.4 | 1.2 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.4 | 4.6 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.4 | 1.5 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.4 | 4.4 | GO:0021759 | globus pallidus development(GO:0021759) |
0.4 | 1.1 | GO:0097187 | dentinogenesis(GO:0097187) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 2.5 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.3 | 1.7 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.3 | 1.0 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.3 | 2.3 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 1.8 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 0.9 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
0.3 | 3.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 2.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.3 | 1.0 | GO:1903045 | neural crest cell migration involved in sympathetic nervous system development(GO:1903045) |
0.3 | 1.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 0.8 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.2 | 0.7 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
0.2 | 0.7 | GO:1903718 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
0.2 | 0.9 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 0.4 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
0.2 | 3.5 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.2 | 5.0 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.2 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.2 | 1.7 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.2 | 1.0 | GO:1904835 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.2 | 0.6 | GO:0009441 | glycolate metabolic process(GO:0009441) |
0.2 | 0.8 | GO:1902725 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) negative regulation of satellite cell differentiation(GO:1902725) |
0.2 | 0.7 | GO:0009956 | radial pattern formation(GO:0009956) |
0.2 | 1.6 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 | 0.7 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.2 | 0.5 | GO:2000854 | positive regulation of corticosterone secretion(GO:2000854) |
0.2 | 0.8 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.5 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.2 | 0.8 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 3.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.2 | 0.6 | GO:0098582 | innate vocalization behavior(GO:0098582) |
0.2 | 4.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 2.2 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.2 | 0.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.5 | GO:0060345 | spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
0.1 | 0.7 | GO:0043553 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 1.4 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 0.8 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.5 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 2.6 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 0.8 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.8 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 2.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 7.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 1.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 1.6 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 1.0 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 5.0 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 2.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 1.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.8 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.1 | 0.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 1.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 1.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 4.0 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 10.9 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.1 | 2.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.5 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.7 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.1 | 0.8 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.1 | 0.5 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.1 | 1.6 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.9 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.7 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 2.9 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 1.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.4 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.1 | 0.5 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.1 | 1.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.3 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.1 | 0.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.9 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.9 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.2 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.1 | 0.5 | GO:0048619 | hindgut morphogenesis(GO:0007442) embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 0.3 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
0.1 | 0.3 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.5 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.1 | 0.3 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
0.1 | 1.8 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 1.9 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 1.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 1.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 2.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.6 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.1 | 1.0 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 11.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 1.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.5 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.2 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.1 | 0.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.7 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.0 | 0.3 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 1.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.3 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.0 | 0.7 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.3 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.3 | GO:0015692 | lead ion transport(GO:0015692) |
0.0 | 0.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.1 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.0 | 0.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 1.0 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.8 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.1 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
0.0 | 0.4 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.0 | 1.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.7 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.7 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.6 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.0 | 0.3 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.0 | 0.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.0 | 1.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.5 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.0 | 1.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 1.6 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.0 | 0.2 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.0 | 1.1 | GO:0072662 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.1 | GO:0014820 | tonic smooth muscle contraction(GO:0014820) artery smooth muscle contraction(GO:0014824) |
0.0 | 3.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.7 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.2 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 0.1 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.0 | 1.3 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.0 | 2.9 | GO:0072164 | ureteric bud development(GO:0001657) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
0.0 | 1.7 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.1 | GO:1902358 | sulfate transmembrane transport(GO:1902358) |
0.0 | 0.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 0.7 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.4 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 1.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 3.7 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 2.3 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.0 | 0.2 | GO:0032525 | negative regulation of neuron maturation(GO:0014043) somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.6 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 1.3 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.0 | 1.6 | GO:0008542 | visual learning(GO:0008542) |
0.0 | 0.6 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.0 | 0.2 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.0 | 0.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.3 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.0 | 0.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 1.1 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 2.0 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 2.6 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.9 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.1 | GO:0036269 | swimming behavior(GO:0036269) |
0.0 | 0.7 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) |
0.0 | 1.3 | GO:0007595 | lactation(GO:0007595) |
0.0 | 1.0 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.0 | 0.1 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.0 | 0.4 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.0 | 0.5 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.0 | 0.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.0 | 0.6 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.0 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.0 | 0.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.1 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.9 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.2 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.1 | GO:1902731 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
0.0 | 0.5 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.4 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.0 | 0.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.2 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 1.1 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.6 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.5 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 1.3 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 0.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 22.6 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
1.3 | 14.8 | GO:0071953 | elastic fiber(GO:0071953) |
1.3 | 4.0 | GO:0043257 | laminin-8 complex(GO:0043257) |
0.6 | 2.9 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.4 | 3.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 12.2 | GO:0032982 | myosin filament(GO:0032982) |
0.3 | 1.2 | GO:0060187 | cell pole(GO:0060187) |
0.3 | 0.9 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.3 | 3.5 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 0.7 | GO:1990032 | parallel fiber(GO:1990032) |
0.2 | 4.3 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 3.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.7 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.1 | 1.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 17.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.9 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 0.9 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 0.7 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 0.3 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.1 | 0.7 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.3 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.1 | 1.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 7.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 1.2 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.8 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.0 | 1.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.8 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 2.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.3 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 1.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 2.7 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.3 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
0.0 | 0.5 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.4 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.8 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 6.1 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 8.8 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.1 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.0 | 0.4 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 1.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.8 | GO:0031674 | I band(GO:0031674) |
0.0 | 3.9 | GO:0000792 | heterochromatin(GO:0000792) |
0.0 | 0.1 | GO:0032997 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
0.0 | 5.6 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 2.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 1.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.8 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 0.5 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 2.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 4.7 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.9 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 7.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.2 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.0 | 1.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.3 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 3.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.2 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 1.7 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 3.0 | GO:0030496 | midbody(GO:0030496) |
0.0 | 5.5 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.8 | GO:0042175 | endoplasmic reticulum membrane(GO:0005789) nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 0.8 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 2.1 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 1.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.8 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.5 | 1.6 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.5 | 9.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 2.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.3 | 2.4 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.3 | 0.8 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 1.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 2.2 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 2.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 4.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 0.6 | GO:0052854 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
0.2 | 2.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.7 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.2 | 0.6 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
0.2 | 0.7 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.2 | 0.5 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.2 | 1.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 1.5 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.2 | 6.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.2 | 0.6 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.2 | 0.5 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
0.2 | 0.8 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.2 | 1.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 0.5 | GO:0097689 | iron channel activity(GO:0097689) |
0.1 | 0.4 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
0.1 | 0.4 | GO:0033961 | cis-stilbene-oxide hydrolase activity(GO:0033961) |
0.1 | 0.5 | GO:0005115 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
0.1 | 16.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.5 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 4.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 4.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.7 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 0.7 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 0.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.5 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.1 | 0.3 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.1 | 0.7 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 3.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 3.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 1.0 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 1.9 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.8 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 1.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.2 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 1.5 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 1.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 2.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 1.6 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 11.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.3 | GO:0001093 | TFIIB-class transcription factor binding(GO:0001093) |
0.0 | 5.6 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 1.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.9 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 3.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 1.4 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.3 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.0 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 2.8 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
0.0 | 1.6 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 10.4 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.2 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) uptake transmembrane transporter activity(GO:0015563) |
0.0 | 0.1 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.0 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.2 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.0 | 0.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 6.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 6.3 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 5.7 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 1.0 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 1.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 3.3 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 1.8 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.0 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
0.0 | 0.7 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 29.1 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.0 | 4.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.4 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.7 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 2.5 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 2.9 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.0 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
0.0 | 1.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 1.0 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 2.5 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.2 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.3 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.0 | GO:0032093 | SAM domain binding(GO:0032093) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 6.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 8.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 3.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 11.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 4.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 7.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 17.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 3.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 1.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 3.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 3.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 1.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 2.6 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 2.1 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 2.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 1.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 1.0 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 3.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 4.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 7.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 5.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 1.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 2.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 3.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 1.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 2.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 1.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 3.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 0.8 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 1.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 5.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 1.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 1.1 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 3.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.8 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 3.9 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.0 | 1.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 0.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 1.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 1.1 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.2 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 1.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 1.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.8 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 2.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |